Dr. Richard has over 24 years of experience in the pharmaceutical industry in leading global clinical development projects, supervising clinical-regulatory strategies, clinical operations, pharmacovigilance, medical affairs, and managing multicultural and cross-functional teams and departments. She has been responsible for the global development of a large number of anti-infectives and vaccines that she led successfully to international registrations.
After six years at Bristol-Myers Squibb as a medical-marketing Manager, Dr Richard joined Aventis Pharma as European Clinical Project Manager in a French-Japanese joint-venture, then as Director in the global anti-infectives corporate clinical department. In 2000, she joined GlaxoSmithKline in the UK as Sr Director with responsibility for a portfolio of anti-infectives. Thereafter Dr Richard was appointed VP Clinical Development in Sanofi Pasteur France . From 2008, she was a Medical Advisor for several biotech companies in Switzerland and France, and for a Capital Venture Fonds.
Dr. Richard is an M.D., she received her diploma in clinical immunology, pharmacology/ pharmacokinetics, and an MBA from CEDEP-INSEAD.
"We are very pleased to see Dr. Richard join the team at AiCuris as CMO. She has a profound background in infectious diseases and a great development and management expertise", comments AiCuris CEO, Prof. Helga Rübsamen-Schaeff.
"I am extremely happy to join the experienced and highly qualified Development team at AiCuris. The R&D portfolio is very promising and I am thrilled with this opportunity to develop this portfolio further at AiCuris and to bring my competences to the Management Team", adds Dr. Marie-Paule Richard.